Inovio Pharmaceuticals (INO) PT Raised to $14 at RBC Capital

March 15, 2018 8:25 AM EDT Send to a Friend

RBC Capital raised its price target on Inovio ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Inovio Pharmaceuticals (INO) PT Raised to $14 at RBC Capital

Member Login

Free News Feed